» Articles » PMID: 10491242

Attitudes and Beliefs of African Americans Toward Participation in Medical Research

Overview
Publisher Springer
Specialty General Medicine
Date 1999 Sep 22
PMID 10491242
Citations 449
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe barriers to participation of African Americans in research.

Design: Focus group interviews conducted in 1997.

Patients: Thirty-three African-American adults presenting to an urban public hospital for outpatient medical care participated in one of five focus groups.

Measurements And Main Results: African-American patients' attitudes toward medical research were measured. Mistrust of doctors, scientists, and the government was reported consistently by the participants. Many participants described concerns about the ethical conduct of clinicians and investigators when poor or minority patients are involved and cited examples of exploitation as supporting evidence for their mistrust of the medical establishment. While participants were clear about the violation of human rights in the Tuskegee Syphilis Study, all were misinformed of the historical facts of the study. Few participants understood the concept of informed consent. Participants saw signing the document as relinquishing their autonomy and as a legal protection for physicians. Despite these concerns, participants gave recommendations to improve minority participation in research.

Conclusions: African-American participants in this study described distrust of the medical community as a prominent barrier to participation in clinical research. Participants described real and perceived examples of exploitation to support their distrust of researchers. The goal of the consent process, to inform patients of risks and benefits so as to facilitate self-determination, was misinterpreted by these participants. Understanding the importance of interpersonal trust within the clinical relationship may prove to be a significant factor in enhancing participation in clinical trials.

Citing Articles

Reporting and representation of participant race and ethnicity in phase III clinical trials for solid tumors.

Wang T, Villanueva D, Banerjee A, Gifkins D Future Sci OA. 2025; 11(1):2458415.

PMID: 39885684 PMC: 11792851. DOI: 10.1080/20565623.2025.2458415.


Exploring the Role of Communication Asset Mapping (CAM) as a Strategy to Promote Hereditary Cancer Risk Assessment Information Within African American Communities.

Lumpkins C, Kaphingst K, Miller L, Cooper E, Smith M, Belshe K Int J Environ Res Public Health. 2025; 22(1).

PMID: 39857528 PMC: 11771212. DOI: 10.3390/ijerph22010075.


Workplace genetic testing: which employees are likely to participate, what are their concerns with employer sponsorship, and which design features could reduce barriers and increase participation?.

Briscoe F, Maxwell J, Bourgoin A Front Genet. 2024; 15:1496900.

PMID: 39698465 PMC: 11652517. DOI: 10.3389/fgene.2024.1496900.


Winning hearts & minds: prostate cancer outreach and clinical trial enrollment in minority men.

Anderson R, Popovic A, Davis M, Kovac E Transl Cancer Res. 2024; 13(11):6430-6437.

PMID: 39697722 PMC: 11651785. DOI: 10.21037/tcr-24-868.


New strategies for enhancing enrollment of underrepresented minorities in lymphoma clinical trials.

Nze C, Herrera A Blood Adv. 2024; 9(4):774-782.

PMID: 39631075 PMC: 11869956. DOI: 10.1182/bloodadvances.2024012981.


References
1.
Truog R, Robinson W, Randolph A, Morris A . Is informed consent always necessary for randomized, controlled trials? . N Engl J Med. 1999; 340(10):804-7. DOI: 10.1056/NEJM199903113401013. View

2.
Tangrea J, Adrianza M, Helsel W . Patients' perceptions on participation in a cancer chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 1992; 1(4):325-30. View

3.
Caplan A . Twenty years after. The legacy of the Tuskegee Syphilis Study. When evil intrudes. Hastings Cent Rep. 1992; 22(6):29-32. View

4.
Edgar H . Twenty years after. The legacy of the Tuskegee Syphilis Study. Outside the community. Hastings Cent Rep. 1992; 22(6):32-5. View

5.
King P . Twenty years after. The legacy of the Tuskegee Syphilis Study. The dangers of difference. Hastings Cent Rep. 1992; 22(6):35-8. View